A 60-year-old man with long-standing type 2 diabetes and microalbuminuria is on ACE inhibitor and SGLT2 inhibitor. His ACR remains 45 mg/mmol. According to Diabetes Canada, what additional therapy may further reduce kidney and cardiovascular risk?AAdd a mineralocorticoid receptor antagonist such as finerenoneBStop SGLT2 inhibitorCUse dual RAAS blockade with ACE inhibitor and ARBDNo additional therapy is ever indicatedEIncrease protein intakeCheck my answer